We Announced the $48.3M Federal Partnership at the White House!
It was incredibly special for me to speak at the White House on Wednesday about our funding from the federal government and what it will mean for patients like me.
While on stage, I couldn’t help but think back to 14 years ago when I was fighting for my life in the ICU. I never could have imagined that one day I would be able to turn those horrible moments into a mission with the potential to help millions of patients all over the world.
The Wall Street Journal Profiled Our Repurposing Work to Help Patients like Kaila
Amy Marcus of the Wall Street Journal profiled Every Cure, the drug repurposing landscape, and patients like Kaila whose life was saved thanks to repurposed drugs that we uncovered! Click here to read the full article.
We are building an AI platform that aims to identify treatments for millions of patients
Every Cure is scaling the approach I used to discover my own cure to unlock additional life-saving uses for every drug. We are using the federal funding to leverage novel AI techniques to analyze the world’s biomedical knowledge and identify 100 potential treatment opportunities in the next five years and advance 25 into further research, including clinical trials. Promising early leads include arginine for sickle cell disease, folinic acid for autism spectrum disorder, and bosutinib for ALS.
Wow, my head is spinning from these recent clinical trial results. Within minutes of one another, two conflicting studies were released. The first I’ll highlight is of tocilizumab (the drug that my friend and colleague Kazu Yoshizaki developed to treat Castleman disease and tested on himself to prove that it was safe before giving it…
When fighting a war, information really matters. You need to know what weapons have been tried and which ones have been most (and least) effective. This information helps soldiers to adjust their strategy. The same holds true when fighting a global war against a disease like COVID19 (or Castleman disease or any disease!). We need…
Inspired by my journey discovering a drug that could be repurposed to save my life, I co-founded Every Cure in September 2022 to unlock the full potential of existing medicines to treat every disease and every patient possible. I had the opportunity to announce Every Cure’s launch during the Opening Session of the Clinton Global…
Congress should encourage companies to repurpose existing drugs for rare diseases, potentially doubling the number of treatment options for patients. Lately, there has been a national uproar over the rising cost of medicine in the U.S. While this is an important public debate, it largely overlooks the critical importance of innovation, which is desperately needed…
It has been amazing to see all of the incredible press and media attention for Chasing My Cure! Check out the various stories below: Chasing My Cure in the press: Good Morning America, August 26, 2019 Philadelphia Magazine, August 28, 2019 Philadelphia Inquirer, September 5, 2019 Next Big Idea Club—Top 6 Nonfiction Books of Fall…
I am beyond honored to be named the 2023 Philadelphia Citizen of the Year by The Philadelphia Citizen. This recognition is a testament to our amazing team’s work and the support that so many of you have shared with us! It has been the honor of a lifetime to work with our amazing teams at…
